Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Copeptin levels and invasive hemodynamics in patients with advanced heart failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. ProANP and proBNP in plasma as biomarkers of heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Commentary: Measurement of biomarkers in medicine

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Fetal cells in maternal blood for prenatal diagnosis: A love story rekindled

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Chromogranin A in the mammalian heart: expression without secretion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Pulmonary artery pressure as a method for assessing hydration status in an anuric hemodialysis patient - a case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Upgrading hypertension treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

AIM: Arginine vasopressin is a potent vasoconstrictory hormone and arginine vasopressin release is upregulated in heart failure (HF). The aim of this study was to evaluate if copeptin (the C-terminal part of provasopressin) is related to invasive hemodynamics in HF.

METHODS & RESULTS: Right heart catheterization was performed in patients with advanced HF referred for evaluation for heart transplantation. Sixty-five patients (mean age 54 ± 12 years, left ventricular ejection fraction 19 ± 8% and median copeptin levels of 16.7 pmol/l (interquartile range: 11-30 pmol/l) were included. In multivariate analysis, increased levels of log (copeptin) were associated with a reduced CI (r = 0.65 and p = 0.04).

CONCLUSION: Increased copeptin levels in plasma are associated with hemodynamic parameters obtained at right heart catheterization in patients with HF, in particular-reduced cardiac index. Copeptin could be a useful biomarker for abnormal resting hemodynamics in HF.

OriginalsprogEngelsk
TidsskriftBiomarkers in Medicine
Vol/bind12
Udgave nummer8
Sider (fra-til)861-870
Antal sider10
ISSN2050-7771
DOI
StatusUdgivet - aug. 2018

ID: 55650369